U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07162064) titled 'Heparin for RAO Post-Transradial Angiography in AIS' on Aug. 26.
Brief Summary: Cerebral angiography is a critical diagnostic tool in neurology, serving as the "gold standard" for evaluating cerebrovascular stenosis, hemodynamics, aneurysms, and arteriovenous malformations. Compared to the traditional transfemoral approach, transradial cerebral angiography (TRA) offers advantages such as preserved patient privacy, immediate post-procedure mobility, shorter hospitalization, and fewer access-site complications. Consequently, TRA has gained increasing acceptance among patients and clinicians as the preferred vascular access . However,...